Navigation Links
Pam Marrone to Speak at Ag 2.0 Conference
Date:4/8/2011

DAVIS, Calif., April 8, 2011 /PRNewswire/ -- On April 12, at the Hilton San Francisco Union Square, Pam Marrone, Founder and CEO of Marrone Bio Innovations (MBI), will address Agriculture 2.0 conference attendees as part of an industry panel debating the topic of 'Feeding a Growing Global Population'. The discussion will explore technologies with the potential to curb environmental impact while producing enough food to feed a projected world population of 9 billion people by 2050.

Marrone's company, Marrone Bio Innovations, discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, plant disease and invasive pest management. The company plays a leading role in developing and supplying effective, natural agricultural products that meet the challenge of delivering higher yields while maintaining a sustainable food production system.

In its 5th annual conference on April 11 & 12, 2011, Ag 2.0 brings together venture capitalists and early-stage companies, as well as senior decision makers in agribusiness and farmland funds, commodities experts, growth stage and institutional investors, and key industry insiders and policy makers. The conference provides a forum for hundreds of investors, entrepreneurs and industry experts to hold panel discussions, presentations, industry roundtables and networking sessions with individuals who will work to catalyze and capitalize sustainable agriculture as an asset class.

About Marrone Bio Innovations

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible natural products that fill unmet needs for weed, plant disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products waiting approval at the EPA, including two insecticides, two herbicides and Zequanox,™ a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI has several new nematicide, insecticide, fungicide and herbicide candidates from its discovery screen.  In addition to its award-winning Regalia® Biofungicide, MBI currently markets GreenMatch®Burndown Herbicide for weed control in organic crop production.  For more information about Marrone Bio Innovations, please go to www.marronebio.com


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations to Present Invasive Mussel Control Solution
2. Marrone Bio Innovations Announces Two New Executive Appointments
3. Marrone Bio Innovations Named an IC20 Company
4. Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey
5. Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations
6. PRA International Expert to Speak at China Drug Safety Summit
7. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
8. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
9. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
10. Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker
11. Bill Gates Named Keynote Speaker at the 2010 mHealth Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):